Beta-blockers after myocardial infarction.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000526:Alprenolol / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000517:prevention & control; D011433:Propranolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000526:Alprenolol; D011433:Propranolol